Disease Markers is a peer-reviewed journal dedicated to the discovery, validation, and application of biomarkers in the diagnosis, prognosis, and monitoring of human diseases. The journal serves as a valuable resource for researchers, clinicians, and industry professionals working to advance the field of personalized medicine. It bridges the gap between basic research and clinical practice, facilitating the translation of scientific discoveries into improved patient outcomes.
Key areas covered include genomics, proteomics, metabolomics, and imaging technologies. The journal publishes original research articles, reviews, and short communications that highlight the identification, characterization, and clinical utility of biomarkers in a wide range of diseases, including cancer, cardiovascular disease, neurological disorders, and infectious diseases. Indexing databases include CAS, Scopus and Web of Science.
By promoting the dissemination of high-quality research and fostering collaboration among experts, Disease Markers aims to accelerate the development and implementation of biomarker-based strategies for disease management. Submit your findings and contribute to the advancement of personalized medicine. Stay ahead of the curve with Disease Markers.